Demand for anything Elon Musk related is booming. The near-billionaire’s brain chip startup, Neuralink, is valued at up to $42 billion in recent secondary market transactions, according to correspondence seen by Business Insider and a person familiar with the matter. That’s a nearly five-fold increase from Neuralink’s last funding round last year, when the startup
Elon Musk’s Neuralink and OpenAI-backed Merge Labs are pushing forward with brain–computer interface (BCI) technology in the U.S. Meanwhile, Chinese serial entrepreneur Phoenix Peng is building rival efforts through two startups: NeuroXess, which develops implantable BCI systems, and a second company, Gestala, developing non-invasive ultrasound-based BCIs. Gestala has raised $21.6 million (CN¥150 million) just two
